Beneficial properties of melatonin in an experimental model of pancreatic cancer-Reference-Cited by-同舟云学术

Beneficial properties of melatonin in an experimental model of pancreatic cancer

Published:2007-10 Issue:3 Volume:43 Page:270-275
ISSN:0742-3098
Container-title:Journal of Pineal Research
language:en
Short-container-title:J Pineal Res

Author:

Ruiz-Rabelo Juan F.,Vázquez Reyes,Perea María D.,Cruz Adolfo,González Raul,Romero Ana,Muñoz-Villanueva María C.,Túnez Isaac,Montilla Pedro,Muntané Jordi,Padillo Francisco Javier

Publisher

Wiley

Subject

Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-079X.2007.00472.x/fullpdf

Reference30 articles.

1. American Gastroenterological Association medical position statement: Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma

2. Pancreatic cancer

3. A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models;Advanced Drug Delivery Reviews;2021-07

2. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress;Cancer Cell International;2021-03-31

3. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways;European Journal of Pharmacology;2020-11

4. Different Effects of Melatonin on X-Rays-Irradiated Cancer Cells in a Dose-Dependent Manner;Dose-Response;2019-07-01

5. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1);Pharmacological Reports;2018-12